CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis

MLA

Shanshui Zhou, et al. “CT-Derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis.” Translational Oncology, vol. 45, no. 101993-, July 2024. EBSCOhost, https://doi.org/10.1016/j.tranon.2024.101993.

APA

Shanshui Zhou, Qi Liu, Yucheng Fu, Lianjun Du, Qiyuan Bao, Zhusheng Zhang, Zhihan Xu, Fuhua Yan, Meng Li, Ruixuan Liu, Le Qin, & Weibin Zhang. (2024). CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis. Translational Oncology, 45(101993-). https://doi.org/10.1016/j.tranon.2024.101993

Chicago

Shanshui Zhou, Qi Liu, Yucheng Fu, Lianjun Du, Qiyuan Bao, Zhusheng Zhang, Zhihan Xu, et al. 2024. “CT-Derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis.” Translational Oncology 45 (101993-). doi:10.1016/j.tranon.2024.101993.